Skip to content

Home
IOncology
Infectious Desease Frontier
IHepatology
Hematology Frontier
Conference topics
Experts Interviews
Informations
Live Broadcasting
Logout

Connecting Medical Expertise through Media

Search for:

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Search for:

Posted inHematology Frontier

September 2 – Roundtable Discussion

Posted by

By Mourabit Halima 2026.10.13Posted inHematology Frontier0 Shares

Home » September 2 – Roundtable Discussion

YouTube player

Views: 151

Share via:

Facebook
X (Twitter)
LinkedIn
More

Last updated on 2026.10.13

Mourabit Halima

Post navigation

Previous Post

Getting to the Bottom of the Debate 2.0 | Metastatic Renal Cell Carcinoma: Extrapolating Second-Line Evidence and Individualizing First-Line Dual Immunotherapy Versus Immunotherapy–TKI Combinations—A Debate Between Professors Xuewen Jiang and Hailiang Zhang

Getting to the Bottom of the Debate 2.0 | Metastatic Renal Cell Carcinoma: Extrapolating Second-Line Evidence and Individualizing First-Line Dual Immunotherapy Versus Immunotherapy–TKI Combinations—A Debate Between Professors Xuewen Jiang and Hailiang Zhang

Next Post

Professor Li Wang: First-Line Treatment Landscape and Controversies in MCL in the BTK Inhibitor Era | 2026 China-France Scientific Symposium on Hematology and Immunology

Professor Li Wang: First-Line Treatment Landscape and Controversies in MCL in the BTK Inhibitor Era | 2026 China-France Scientific Symposium on Hematology and Immunology

LinkedIn
Twitter
Mail

Related Media:

Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
Paris, France

Facebook
X (Twitter)
LinkedIn
More Networks

Share via

Copy link

CopyCopied